Retractable Technologies Inc (RVP)
1.02
+0.04
(+4.08%)
USD |
NYAM |
May 17, 16:00
1.02
0.00 (0.00%)
After-Hours: 20:00
Retractable Technologies SG&A Expense (Quarterly): 4.158M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.158M |
September 30, 2023 | 5.106M |
June 30, 2023 | 5.271M |
March 31, 2023 | 5.480M |
December 31, 2022 | 12.01M |
September 30, 2022 | 5.322M |
June 30, 2022 | 5.502M |
March 31, 2022 | 5.746M |
December 31, 2021 | 5.632M |
September 30, 2021 | 5.230M |
June 30, 2021 | 6.569M |
March 31, 2021 | 4.424M |
December 31, 2020 | 3.518M |
September 30, 2020 | 3.346M |
June 30, 2020 | 2.588M |
March 31, 2020 | 2.911M |
December 31, 2019 | 2.971M |
September 30, 2019 | 2.654M |
June 30, 2019 | 2.487M |
March 31, 2019 | 2.538M |
December 31, 2018 | 2.743M |
September 30, 2018 | 2.710M |
June 30, 2018 | 2.865M |
March 31, 2018 | 2.872M |
December 31, 2017 | 3.191M |
Date | Value |
---|---|
September 30, 2017 | 3.133M |
June 30, 2017 | 3.357M |
March 31, 2017 | 3.329M |
December 31, 2016 | 3.561M |
September 30, 2016 | 3.223M |
June 30, 2016 | 3.077M |
March 31, 2016 | 2.959M |
December 31, 2015 | 3.017M |
September 30, 2015 | 3.297M |
June 30, 2015 | 3.674M |
March 31, 2015 | 3.177M |
December 31, 2014 | 3.406M |
September 30, 2014 | 3.302M |
June 30, 2014 | 3.326M |
March 31, 2014 | 3.528M |
December 31, 2013 | 3.641M |
September 30, 2013 | 3.875M |
June 30, 2013 | 3.926M |
March 31, 2013 | 3.962M |
December 31, 2012 | 3.932M |
September 30, 2012 | 3.321M |
June 30, 2012 | 3.697M |
March 31, 2012 | 3.294M |
December 31, 2011 | 3.787M |
September 30, 2011 | 3.247M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.487M
Minimum
Jun 2019
12.01M
Maximum
Dec 2022
4.786M
Average
5.106M
Median
Sep 2023
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 5.878M |
InfuSystems Holdings Inc | 17.07M |
Xtant Medical Holdings Inc | 20.24M |
Asensus Surgical Inc | 8.016M |
Catheter Precision Inc | 2.656M |